Antimicrobial Agents — MCQs

Antimicrobial Agents Indian Medical PG Practice Questions and MCQs

Question 1451: Which drug is used as first-line treatment for acute bacterial sinusitis?

A. Ciprofloxacin
B. Azithromycin
C. Doxycycline
D. Amoxicillin-clavulanate (Correct Answer)

Explanation: ***Amoxicillin-clavulanate*** - This is generally recommended as the **first-line antibiotic** for acute bacterial sinusitis in adults and children due to its broad spectrum of activity against common respiratory pathogens like *Streptococcus pneumoniae* and *Haemophilus influenzae*, including beta-lactamase-producing strains. - The **clavulanate component** helps overcome bacterial resistance to amoxicillin by inhibiting beta-lactamase enzymes, making it effective against a wider range of bacteria. *Ciprofloxacin* - This is a **fluoroquinolone** antibiotic, typically reserved for **second-line treatment** of acute bacterial sinusitis, especially in cases of antibiotic failure or severe penicillin allergy. - Its use is generally avoided as a first-line choice due to concerns about increasing **antibiotic resistance** and potential side effects like tendinopathy and *Clostridioides difficile* infection. *Azithromycin* - This is a **macrolide antibiotic** that may be used in patients with **penicillin allergy**, but it's not considered first-line for acute bacterial sinusitis because of increasing rates of **macrolide resistance** among *Streptococcus pneumoniae*. - Its **narrower spectrum** against common sinusitis pathogens compared to amoxicillin-clavulanate makes it less ideal as initial therapy. *Doxycycline* - This is a **tetracycline antibiotic** that can be considered as an alternative for patients with **penicillin allergy** for acute bacterial sinusitis. - However, it is not typically preferred as a first-line agent over amoxicillin-clavulanate, given its potential side effects and the established efficacy and safety profile of beta-lactams.

Question 1452: Which antiviral drug class is most effective in treating influenza by inhibiting the neuraminidase enzyme?

A. Protease inhibitors
B. Neuraminidase inhibitors (Correct Answer)
C. Nucleotide analogs
D. Integrase inhibitors

Explanation: ***Neuraminidase inhibitors*** - This class of drugs, which includes **oseltamivir** and **zanamivir**, specifically targets the **neuraminidase** enzyme of the influenza virus. - By inhibiting neuraminidase, these drugs prevent the release of newly formed **virions** from infected cells, thus stopping viral propagation and spread. *Protease inhibitors* - These drugs are primarily used in the treatment of **HIV** and **hepatitis C virus** infections. - They work by blocking the activity of viral **protease enzymes** essential for cleaving viral polyproteins into functional proteins. *Nucleotide analogs* - This class of antiviral drugs, such as **acyclovir** and **remdesivir**, is used to treat various viral infections like **herpesviruses** and **Ebola**. - They act by mimicking natural **nucleotides** and are incorporated into growing viral DNA or RNA chains, leading to **chain termination** and inhibition of viral replication. *Integrase inhibitors* - These drugs are specifically used in the treatment of **HIV infection**. - They work by blocking the activity of the **HIV integrase enzyme**, which is responsible for integrating viral DNA into the host cell's genome.

Question 1453: In the context of HIV treatment, what is the primary purpose of combining multiple antiretroviral medications?

A. To reduce the pill burden
B. To increase the mutation rate of the virus
C. To prevent the development of resistance (Correct Answer)
D. To target different organs infected with HIV

Explanation: ***To prevent the development of resistance*** - HIV has a **high mutation rate** due to its RNA genome and error-prone reverse transcriptase, allowing it to rapidly develop resistance to single antiretroviral drugs. - Combining multiple drugs that target different stages of the viral life cycle ensures that even if one drug's target mutates, other drugs can still inhibit viral replication, thereby **suppressing viral evolution** and minimizing resistance. *To reduce the pill burden* - While single-pill regimens combining multiple drugs exist, the primary goal of combining different antiretrovirals is not to reduce the number of pills, but rather to **enhance efficacy and prevent resistance**. - Reducing pill burden is a secondary benefit or an aim of drug formulation, not the fundamental purpose of combination therapy itself. *To increase the mutation rate of the virus* - This statement is incorrect; the goal of HIV treatment is to **decrease viral replication** and thus reduce the opportunity for new mutations to occur, not to increase them. - An increased mutation rate would be detrimental, leading to more rapid drug resistance and treatment failure. *To target different organs infected with HIV* - While HIV can infect various cell types and organs, the primary goal of combination antiretroviral therapy (cART) is to **reduce the viral load throughout the body** by inhibiting viral replication, regardless of the specific organ. - Different drugs target different steps of the viral life cycle, not necessarily different organ systems, but achieving systemic viral suppression benefits all affected tissues.

Question 1454: A patient with a history of recurrent cold sores is being evaluated for antiviral therapy. Which phase of the herpes simplex virus lifecycle is targeted by acyclovir, and why is it effective?

A. Viral DNA replication; acyclovir inhibits viral DNA polymerase (Correct Answer)
B. Viral entry; acyclovir blocks viral fusion with the host cell membrane
C. Latency; acyclovir induces viral genome degradation
D. Viral assembly; acyclovir prevents virion packaging

Explanation: Acyclovir is a nucleoside analog that, once activated by viral thymidine kinase, preferentially inhibits viral DNA polymerase, thus preventing the replication of the herpes simplex virus (HSV) genome [1, 2]. The drug's selectivity for viral DNA polymerase over host DNA polymerase, along with its activation by a viral enzyme, leads to effective antiviral action with minimal host cell toxicity [1]. Acyclovir does not directly interfere with the initial viral entry or fusion processes, which are typically mediated by viral glycoproteins interacting with host cell receptors [3]. Drugs that block viral entry, such as docosanol (topical), work through different mechanisms by inhibiting direct fusion between the herpes virus envelope and the human cell plasma membrane. Acyclovir is effective against actively replicating HSV and does not target the latent phase of infection, where the viral genome remains dormant within nerve ganglia. During latency, the virus does not produce viral thymidine kinase, so acyclovir cannot be phosphorylated and activated to inhibit DNA replication, nor does it induce viral genome degradation [1]. Acyclovir’s primary mechanism of action is inhibiting DNA replication [1]. While preventing DNA replication indirectly hinders the overall viral lifecycle, acyclovir itself does not directly interfere with the process of assembling newly synthesized viral components into mature virions.

Question 1455: A 58-year-old male presents with fever, cough, and pleuritic chest pain. His sputum culture grows Streptococcus pneumoniae (penicillin-sensitive). For outpatient oral therapy, what is the most appropriate antibiotic?

A. Amoxicillin (Correct Answer)
B. Azithromycin
C. Ciprofloxacin
D. Vancomycin

Explanation: **Amoxicillin** (Correct Answer) - **Amoxicillin** is the first-line agent for community-acquired pneumonia caused by **penicillin-sensitive Streptococcus pneumoniae** due to its excellent efficacy, safety profile, and narrow spectrum. - Given that the organism is confirmed to be **penicillin-sensitive**, amoxicillin is the most appropriate choice for **outpatient oral therapy**. - It provides adequate coverage with minimal collateral damage and is cost-effective. *Azithromycin* (Incorrect) - While **azithromycin** covers atypical pathogens and is commonly used empirically for community-acquired pneumonia, its use for penicillin-sensitive *S. pneumoniae* is less effective than amoxicillin due to increasing macrolide resistance in some *S. pneumoniae* strains. - It would be a consideration if atypical pathogens were suspected or if the patient had a penicillin allergy, neither of which is indicated here. *Ciprofloxacin* (Incorrect) - **Ciprofloxacin** is a fluoroquinolone mainly used for gram-negative infections, complicated urinary tract infections, and sometimes for pneumonia, but it is generally reserved for situations where other antibiotics are not suitable or for specific indications like **Pseudomonas aeruginosa**. - Its broad-spectrum nature and potential for **collateral damage** (e.g., *C. difficile* infection, resistance development) make it a less preferred choice when a penicillin-sensitive organism is identified and a narrower-spectrum agent is available. *Vancomycin* (Incorrect) - **Vancomycin** is an intravenous antibiotic used for **methicillin-resistant Staphylococcus aureus (MRSA)** or **penicillin-resistant S. pneumoniae**, which is not the case here. - It is not available as an oral formulation for systemic infections (oral vancomycin is only used for *C. difficile* colitis) and would be inappropriate for **outpatient oral therapy** of penicillin-sensitive *S. pneumoniae*.

Question 1456: A 30-year-old female presents with fatigue and difficulty swallowing. An endoscopic biopsy reveals budding yeast cells with pseudohyphae. Which antifungal therapy is the most appropriate?

A. Amphotericin B
B. Fluconazole (Correct Answer)
C. Griseofulvin
D. Terbinafine

Explanation: ***Fluconazole*** - This patient's symptoms (fatigue, difficulty swallowing) and endoscopic biopsy findings (**budding yeast cells with pseudohyphae**) are highly suggestive of **oesophageal candidiasis [1], [2]**. - **Fluconazole** is the **first-line treatment** for uncomplicated oesophageal candidiasis due to its good oral bioavailability [3] and efficacy against *Candida* species [2], [3]. *Amphotericin B* - **Amphotericin B** is a potent antifungal but is typically reserved for **severe, invasive fungal infections [2]** or infections resistant to fluconazole [1]. - It has significant side effects, including **nephrotoxicity** and infusion-related reactions [4], making it unsuitable for a first-line treatment of uncomplicated oesophageal candidiasis. *Griseofulvin* - **Griseofulvin** is an antifungal primarily used to treat **dermatophytosis** (e.g., ringworm, athlete's foot) and **onychomycosis [2]**. - It is **inactive against *Candida* species** and therefore would not be effective for oesophageal candidiasis [2]. *Terbinafine* - **Terbinafine** is an antifungal mainly used for **dermatophyte infections** like tinea pedis and onychomycosis [2], [3]. - It is not effective against candidal infections and is **not indicated** for oesophageal candidiasis [3].

Question 1457: A patient undergoing chemotherapy requires prophylactic treatment to prevent infection. Which drug is commonly prescribed for Pneumocystis pneumonia prophylaxis?

A. Doxycycline
B. Sulfadiazine
C. Trimethoprim-sulfamethoxazole (Correct Answer)
D. Clindamycin

Explanation: ***Trimethoprim-sulfamethoxazole*** - This combination antibiotic is the **most commonly prescribed and highly effective** agent for preventing **Pneumocystis pneumonia (PCP)** in immunocompromised patients, including those undergoing chemotherapy. - It works by inhibiting **folate synthesis** in *Pneumocystis jirovecii*, thereby preventing its proliferation. *Doxycycline* - **Doxycycline** is a tetracycline antibiotic primarily used for bacterial infections like pneumonia and skin infections, or for malaria prophylaxis. - It is **not effective** against *Pneumocystis jirovecii* and therefore not used for PCP prophylaxis. *Sulfadiazine* - **Sulfadiazine** is a sulfonamide antibiotic that can be used to treat toxoplasmosis, but it is **not the first-line or most effective agent** for PCP prophylaxis when used alone. - It is a component of trimethoprim-sulfamethoxazole, where the combined action is crucial for PCP prevention. *Clindamycin* - **Clindamycin** is a lincosamide antibiotic primarily used for anaerobic bacterial infections and certain protozoal infections like toxoplasmosis in combination with pyrimethamine. - It has **no significant role** in the prevention of **Pneumocystis pneumonia**.

Question 1458: Which component of the bacterial cell wall is targeted by antibiotics to inhibit cell wall synthesis?

A. Lipopolysaccharides
B. Peptidoglycan (Correct Answer)
C. Plasma membrane
D. Capsule

Explanation: ***Peptidoglycan*** - The **peptidoglycan** layer is a crucial and unique component of bacterial cell walls, responsible for maintaining cell shape and integrity. - Many common antibiotics, such as **penicillins and cephalosporins (beta-lactams)**, specifically target the synthesis of **peptidoglycan**, weakening the cell wall and leading to bacterial lysis. *Lipopolysaccharides* - **Lipopolysaccharides (LPS)** are found exclusively in the outer membrane of **Gram-negative bacteria** and contribute to their structural integrity and act as an endotoxin. - While important for bacterial virulence, LPS are not the primary target for antibiotics aiming to inhibit cell wall synthesis itself. *Plasma membrane* - The **plasma membrane** is present in both bacterial and eukaryotic cells and regulates the passage of substances; targeting it can harm host cells. - Although some antibiotics (e.g., polymyxins) target bacterial membranes, the direct inhibition of cell wall synthesis is not their primary mechanism of action. *Capsule* - The **bacterial capsule** is an outer layer composed of polysaccharides or polypeptides that protects bacteria from phagocytosis and aids in adhesion; it is not essential for cell wall integrity. - Antibiotics do not typically target the capsule to inhibit cell wall synthesis, as its removal does not directly lead to cell lysis.

Question 1459: Which antiviral drug inhibits DNA polymerase, effectively preventing viral replication in herpes viruses?

A. Oseltamivir
B. Acyclovir (Correct Answer)
C. Ritonavir
D. Zidovudine

Explanation: ***Acyclovir*** - Acyclovir is a **guanosine analog** that is selectively phosphorylated by **herpes viral thymidine kinase** within infected cells. - The activated form then inhibits **viral DNA polymerase**, leading to chain termination and preventing viral replication. *Oseltamivir* - Oseltamivir is an **antiviral medication** used to treat and prevent **influenza A and B** by inhibiting the viral enzyme **neuraminidase**. - It does not target **herpes viruses** or their **DNA polymerase**. *Ritonavir* - Ritonavir is an **antiretroviral drug** primarily used to treat **HIV infection**, often as a **pharmacokinetic booster** for other protease inhibitors. - It works by inhibiting **HIV protease**, not DNA polymerase of herpes viruses. *Zidovudine* - Zidovudine (AZT) is a **nucleoside reverse transcriptase inhibitor (NRTI)** used in the treatment of **HIV infection**. - It works by inhibiting **reverse transcriptase**, an enzyme unique to retroviruses, and is not active against herpes viral DNA polymerase.

Question 1460: Which of the following vaccines is inactivated?

A. Japanese encephalitis
B. Poliomyelitis
C. Typhoid
D. Rabies vaccine (Correct Answer)

Explanation: ***Rabies vaccine***- The **rabies vaccine** is a classic example of an **inactivated vaccine**, meaning it contains killed viral particles [1].- Inactivated vaccines cannot replicate, making them safer for immunocompromised individuals, but often require **multiple doses** and boosters to achieve robust immunity [1].*Japanese encephalitis*- The **Japanese encephalitis vaccine** can be either **inactivated (e.g., IXIARO, JE-VC)** or **live-attenuated (e.g., IMOJEV, SA14-14-2)**.- The question asks for a vaccine that *is* inactivated, and while an inactivated form exists, other options are exclusively inactivated, making them a more direct answer to the question.*Poliomyelitis*- There are two main types of poliomyelitis vaccines: the **inactivated poliovirus vaccine (IPV)**, which is given by injection [1], and the **oral poliovirus vaccine (OPV)**, which is **live-attenuated**.- Because **OPV is live-attenuated**, poliomyelitis is not exclusively an inactivated vaccine, despite the existence of IPV.*Typhoid*- The **typhoid vaccine** comes in a **live-attenuated oral form (Ty21a)** and an **inactivated polysaccharide injectable form (ViCPS)**.- Similar to poliomyelitis and Japanese encephalitis, the existence of a live-attenuated version means typhoid is not exclusively an inactivated vaccine.

Practice by Chapter

Beta-Lactam Antibiotics

Practice Questions

Aminoglycosides

Practice Questions

Macrolides and Ketolides

Practice Questions

Tetracyclines

Practice Questions

Quinolones

Practice Questions

Sulfonamides and Trimethoprim

Practice Questions

Antimycobacterial Drugs

Practice Questions

Antifungal Agents

Practice Questions

Antiviral Drugs

Practice Questions

Antiparasitic Agents

Practice Questions

Principles of Antimicrobial Selection

Practice Questions

Antimicrobial Resistance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free